Credit Suisse’s ResMed RMD Stock Holding History

Credit Suisse’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-25,000	Closed	-$1.8M	–	3938
2017 Q1	$1.8M	Buy	+25,000	New	+$1.73M	﹤0.01%	2421

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's RMD Position: Q1 2024 in Review

Credit Suisse increased its ResMed (RMD) stake by 5.9% in Q1 2024, buying an estimated $2.18M and bringing the position to 214,354 shares worth $42.4M. The position accounts for 0.04% of the portfolio, ranked #411.

Credit Suisse first reported a position in RMD in Q2 2013 and has held it in 44 quarters since. The position peaked at $75.2M in Q3 2021. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

Credit Suisse held 214,354 shares of ResMed worth $42.4M as of Q1 2024.
Credit Suisse bought 11,916 ResMed shares in Q1 2024, an estimated $2.18M.
ResMed made up 0.04% of Credit Suisse's portfolio in Q1 2024, its #411 holding.
Credit Suisse first reported a position in ResMed in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's ResMed position peaked at $75.2M in Q3 2021.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.